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Abstract: The complex architecture of the lung parenchyma and the air-blood barrier is difficult 
to mimic in-vitro. Recently reported lung-on-a-chips used a thin, porous and stretchable PDMS 
membrane, to mimic the air-blood barrier and the rhythmic breathing motions. However, the 
nature, the properties and the size of this PDMS membrane differ from the extracellular matrix of 
the distal airways. Here, we present a second-generation lung-on-a-chip with an array of in vivo-
like sized alveoli and a stretchable biological membrane. This nearly absorption free membrane 
allows mimicking in vivo functionality of the lung parenchyma at an unprecedented level. The 
air-blood barrier is constituted by human primary lung alveolar epithelial cells from several 
patients and co-cultured with primary lung endothelial cells. Typical markers of lung alveolar 
epithelial cells could be observed in the model, while barrier properties were preserved for up to 
three weeks. This advanced lung alveolar model reproduces some key features of the lung 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/608919doi: bioRxiv preprint first posted online Apr. 18, 2019; 
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
13
42
62
 
| 
do
wn
lo
ad
ed
: 
4.
12
.2
01
9
2 
 
alveolar environment in terms of composition, alveolar size, mechanical forces and biological 
functions, which makes this model a more analogous tool for drug discovery, diseases modeling 
and precision medicine applications. 
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Organs-on-chips (OOCs) are emerging as predictive tissue modelling tools and as a credible 
alternative to animal testing. These micro-engineered, cell-based systems provide cells with an 
environment that closely resembles their native in vivo milieu1,2,3. Tissue models of 
physiologically healthy or pathological primary cells from patients have been established, and 
are robust enough to permit applications such as drug screening4,5,6. Micro-engineered systems 
with an integrated membrane in a microfluidic setting have been reported to model various 
barrier tissue interfaces, such as those of the lung alveoli, the brain and the gut7. By 
implementing a flexible polymeric membrane in such microfluidic systems, mechanical forces, 
such as those induced by breathing, could be reproduced8,9,10.  
 
An important limitation of these in vitro models is the use of an artificial basal membrane made 
of polydimethylsiloxane (PDMS) seeded with cells for culture. Although PDMS has good 
elastic, optical and biocompatible properties, it can distort the biochemical microenvironment 
through high adsorption and absorption levels of small molecules11. In addition, the non-
biological PDMS differs in important ways from the molecular composition and intrinsic 
stiffness of the native extracellular matrix (ECM), which is known to affect cellular phenotype 
and homeostasis12,13. A complex ECM environment provides the structural basis for cellular 
growth, and influences cellular morphology, functionality, differentiation and other traits14,15. 
The role of the ECM in tissue development and function is closely associated with its 
composition  and properties16. The replacement of PDMS as culturing membrane with a material 
made of ECM molecules would therefore be a significant step towards emulating in vivo-like 
tissue barriers and functions.  
 
Hydrogels are currently being used extensively in cell culture systems to recreate the chemical 
composition and structure of the native extracellular matrix17,18. Their intrinsic properties19, 
including mechanical features, chemical composition and porosity, make them ideal candidates 
to supersede PDMS membranes. However, the creation of thin membranes made of ECM 
molecules, with stretchable properties to mimic the cyclic mechanical strain of the lung alveolar 
barrier, is technically challenging and has not yet been achieved. Lo and colleagues reported a 
thin, cellularised collagen membrane integrated into a microfluidic-based blood oxygenator 
being developed as an extracorporeal lung support20. More recently, collagen membranes have 
been integrated into microfluidic devices for use as cell culture substrates. These membranes 
were either cast21,22, compressed23 or spin-coated24 on a PDMS surface prior to being sandwiched 
between two microfluidic structures. The resulting thicknesses of these membranes, not designed 
to be stretched, were between 15 and 30m. Harris and colleagues reported the use of a 
stretchable collagen membrane to determine the mechanical properties of a monolayer of cells. 
They found that the mechanical properties of the layer were dependent on the integrity of the 
actin cytoskeleton, myosin and intercellular adhesions interfacing adjacent cells25. Dunphy et al. 
added elastin to collagen and developed a stretchable and soft membrane for tissue engineering. 
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However, with a thickness of about 1mm, it was developed to evaluate the mechanical properties 
of the material and not to mimic the air-blood barrier26. 
 
Here, we report a unique, biological, thin and stretchable air-blood barrier made of collagen and 
elastin. Unlike all other lung alveolar models reported so far, an array of tiny stretchable alveoli 
with physiological dimensions is reproduced. A thin gold mesh with a pore size of 260µm is 
used as the scaffold, supporting the array of 40 alveoli. The uncomplicated production process of 
the membrane allows straightforward modifications of the system that permit a wide variety of 
investigations of physiological and pathological phenomena. The membrane is created by drop-
casting a collagen-elastin (CE) solution onto the gold mesh, where it spreads and is maintained 
by surface tension (Fig. 1). The resulting membrane is stable and can be cultured on both sides 
for weeks. Its permeability further allows cells to be cultured at the air-liquid interface, and its 
elastic properties mimic the respiratory motions by mechanically stretching the cells. Results 
with primary human alveolar epithelial cells from patients co-cultured with primary human lung 
endothelial cells demonstrate that the air-blood barrier functions can be maintained and used 
experimentally in a resilient and reproducible manner. This proto-physiological membrane opens 
the way to a new generation of lung-on-a-chip and OOC devices that enable the mimicry of 
biological barriers with a new level of analogy to whole organ systems.  
 
Results  
 
Production of a thin, biological and stretchable membrane 
A simple process was used to create the thin biological membrane (Fig. 1). A drop of CE 
solution was pipetted onto a 2mm-diameter and 15µm-thin gold mesh (Fig. 1C and 2A) made of 
an array of 40 regular hexagons, with sides of 130µm separated by 30µm-wide walls. Once 
pipetted onto the mesh, the CE drop was maintained on its top by surface tension forces. After a 
gelation step at 37°C, the CE solution dries out at room temperature within two days. While 
water evaporates from the drop, surface tension forces and residual forces counteract gravity 
force enabling the suspended membrane to form (Fig. 1H). Figures 2B-D illustrate the dried CE-
membrane with a thickness of only a few micrometers that is suspended on the hexagons array. 
Once dried, the membrane was integrated into a microfluidic chip, where it was sandwiched 
between two microfluidic parts, a top part in PDMS with an apical reservoir and a bottom part in 
polycarbonate that formed the basolateral chamber (Sup. Fig. 1). The dried membranes are 
robust and can be stored for at least 3 weeks at room temperature. The membranes are rehydrated 
by submersion in cell culture medium for 2h prior to cell seeding.  
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Properties of the CE-membrane 
The thickness of the membrane was evaluated using reflective light. With a CE ratio of 1:1, the 
thinnest membrane obtained had a thickness of 4.5 ± 0.8µm for a pipetted CE solution volume of 
0.8µL/mm2 (Fig. 2E). When the pipetted volume was doubled (1.6µL/mm2), the thickness of the 
membrane also doubled (8.8 ± 1µm). A thickness of 11.5 ± 1.2µm was obtained with 
2.4µL/mm2. Decreasing the elastin concentration (2:1 ratio) resulted in a reduction of the 
membrane thickness (Sup. Fig. 2), to the detriment of its viscoelastic properties (Fig. 3C). The 
membrane thickness was homogeneous within each hexagon. Variation in membrane thickness 
across the array was less than 20% (Sup. Fig. 3) with a pipetted volume of 1.6µL/mm2. Confocal 
(Fig. 2D) and transmission electron microscopy (TEM) imaging (Fig. 7B) of the membrane 
cross-section confirmed these findings.  
 
The optical properties of the CE-membrane were assessed by light spectrometry. The CE-
membrane performed better than a polyester (PET) membrane of standard Transwell inserts. The 
10µm-thin CE-membrane absorbed about 10% of visible light, whereas a 10µm-thin PET 
membrane with 0.4µm pores used in inserts absorbed about 20% (Fig. 2F). This low absorbance 
level was also obtained for a 2:1 ratio CE-membrane and for a collagen membrane (Sup. Fig. 4). 
The excellent optical properties of the CE-membrane were qualitatively confirmed by text placed 
at the backside of the membrane that was easily read from the apical side (Fig. 2A).  
 
Absorption and adsorption of small molecules on the membrane were tested using exposure to 
rhodamine B. Compared with PDMS and with the PET membranes of similar thicknesses, the 
CE-membrane absorbed much less rhodamine B. After 2h of immersion in 10µM rhodamine B, 
the number of fluorescent molecules ab/adsorbed was about 90% lower in a 10µm-thin CE-
membrane than in the PDMS and the PET membranes (p-value < 0.0001) (Fig. 2G). The 
absorptions/adsorptions of all polymeric membranes tested are higher than those of all biological 
membranes (Sup. Fig. 5). This absorption difference is illustrated in Figure 2H, which shows the 
PDMS and CE-membranes after 2h incubation time with rhodamine B. Using the same imaging 
setting parameters, the PDMS membrane absorbs more rhodamine B than the CE-membrane.  
 
The stretchability of the CE-membrane was tested by applying a cyclic negative pressure to the 
basolateral chamber. The membranes of the 40 hexagons deflect simultaneously and 
homogeneously in three dimensions (Fig. 3B and Sup. Fig. 6). For the 1:1 CE-membrane, the 
applied radial strain reaches 4.9% ± 0.8% for a negative pressure of 1.0kPa, and almost doubles 
(9.2% ± 2.5%) when -2.0kPa is applied (Fig. 3C). Figure 3A shows a numerical simulation of the 
deflection of the membranes in the array of hexagons. When the elastin concentration was 
decreased, the membrane became stiffer, which resulted in smaller linear strains. For example, at 
-1.5kPa, the radial strain was 5.0% ± 1.4% for a 2:1 ratio, whereas it attained 7.6% ± 1.2% for a 
1:1 ratio (Fig. 3C). The gold mesh slightly deflected during the experiments, but this did not 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/608919doi: bioRxiv preprint first posted online Apr. 18, 2019; 
6 
 
influence the individual deflection of the membrane in each hexagon (Sup. Movie). When lung 
alveolar epithelial cells were seeded onto the membrane, 4.0kPa was needed to induce a 10% 
linear mechanical strain (Fig. 3D).  
 
The CE-membrane permeability was assessed by the apical-basolateral transport of two 
molecules with different molecular weights: FITC-Sodium (0.4kDa) and RITC-Dextran (70kDa). 
After 4h of incubation, 25.5% ± 4% of the smaller molecules and 12.0% ± 3.7% of the larger 
molecules were detected in the basolateral chamber (Sup. Fig. 7). The permeability of the 
membrane was further tested by culturing cells at the apical side of the membrane at the air-
liquid interface. In these culture conditions, the nutrients diffuse from the basolateral to the 
apical side of the membrane. Lung alveolar epithelial cells were successfully cultured at the air-
liquid interface for several days (Fig. 4 and Sup. Fig. 8). The cells were confluent and created a 
functional barrier (see below). 
 
The CE-membrane, a good cell culture support 
Human primary alveolar epithelial cells (hAEpCs) and human lung microvascular 
endothelial cells (VeraVec) were successfully cultured on each side of the membrane. The cells 
tightly adhered to the collagen and the elastin as illustrated in the TEM picture of the membrane 
cross-section (Sup. Fig. 9). Lung epithelial cells seeded at high and low density spread and 
proliferated on the membrane (Fig. 5A and Sup. Fig. 10). A significant difference in cellular 
surface area was observed between day 2 and day 8 between high and low seeding concentration 
(p < 0.01) (Fig. 5B). At high seeding density, cell confluence was reached at day 2. The cellular 
surface area remained at 1400 ± 160µm2, whereas it increased to almost 2500 ± 136µm2 at low 
seeding concentration. After 2 weeks, primary human lung alveolar epithelial cells were 
confluent showing nice cell-cell contacts and microvilli (Fig. 5E, F). Primary human lung 
alveolar epithelial cells and primary human endothelial cells could both be cultured for at least 3 
weeks (Sup. Fig. 11).  
 
Reproduction of the lung alveolar barrier  
The typical phenotypes of lung alveolar epithelial cells were investigated using TEM imaging 
and immunostaining. The characteristic morphologies of type I (ATI) and type II (ATII) lung 
alveolar epithelial cells – flat and elongated for ATI (Fig. 7B), small and cuboidal for ATII27 
(Fig. 5D) – were recognisable by TEM imaging. Tight junctions, a further characteristic of lung 
alveolar epithelial cells, were clearly identifiable in Figure 6C. Zonula occludens (ZO-1) were 
expressed along the cell borders at day 4 (Fig. 5C) and day 21 (Sup. Fig. 11). Surfactant protein-
C (SP-C) and lamellar bodies, both typical ATII markers, are shown in Figure 5C, and Figure 
5D, respectively.  
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The permeability of the CE-membrane with a monolayer of lung alveolar epithelial cells was 
further assessed by testing the diffusion capacity of the two molecules used earlier (FITC-
Sodium, RITC-Dextran) as show in Figure 6A. The experiment was performed between days 5 
and 8 to guarantee the confluence of the epithelial layer. The transport properties of the 
membrane were significantly affected by the presence or absence of cells. For FITC-Sodium and 
RITC-Dextran molecules, 24.7% ± 3.5% and 12.3% ± 2.9%, respectively, were transported 
through the membrane without cells against 9.4% ± 3.2% and 2.1% ± 1.2%, respectively, with 
hAEpCs. This result was confirmed with cells from four patients (Fig. 6B). 
 
To further reproduce the lung alveolar barrier, human lung microvascular endothelial cells were 
cocultured on the basolateral side of the membrane, with lung alveolar epithelial cells on the 
apical side. Both cell types reached confluence and populated the whole array (Fig. 7A). Figure 
7B illustrates a close-up of the alveolar barrier, with the CE-membrane sandwiched between the 
alveolar epithelium and the microvascular endothelium.  
 
 
Discussion  
 
The lung parenchyma comprises of a large number of tiny alveoli organised in a three-
dimensional architecture. Thin alveolar walls made of capillary networks and connective tissue 
separate the alveoli and stabilise the parenchymal construction27,28. This complex and dynamic 
environment makes the lung alveolar unique and difficult to mimic in vitro. First-generation 
lung-on-a-chip devices imitate the rhythmic mechanical strain of the alveolar barrier induced by 
breathing motions8,9. Although these systems allow investigation of the mechanobiology of the 
air-blood barrier for the first time, they are limited by the nature of the PDMS membrane they 
are made of. The main drawback of PDMS is that it is synthetic which limits its function and the 
ability to mimic physiological capacities. The ECM of the lung alveolar region has structural and 
mechanical cell substrate functions but beyond that the ECM is pivotal in determining normal 
cellular function and differentiation in health and dysregulation in disease12,29,30. Another 
limitation of PDMS membranes is the absorption and adsorption of small molecules and the 
effect on the ECM as local reservoir of growth factors and bioactive molecules, which are not 
maintained by the microenvironment at physiological concentrations, and therefore distort 
effects in the system. This is also a major concern for preclinical drug testing applications, as the 
effective drug concentration that cells are exposed to is difficult to evaluate11. A further 
drawback is the rather laborious and challenging fabrication process of ultrathin and porous 
PDMS membranes9,31. In addition, first-generation lung-on-a-chip devices imperfectly reproduce 
the geometric dimensions of the native lung alveoli, as the surface of the culturing membrane 
creates a unique alveolus of non-physiological dimensions, rather than an array of alveoli of in 
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vivo-like anatomy. This limits investigations of structural and biomechanical changes of alveoli 
such as those observed in the formation of emphysema29. 
 
Here, we present a second-generation lung-on-a-chip with an array of alveoli and a stretchable 
biological membrane that mimics in vivo functionality at an unprecedented level. The CE-
membrane reproduces the composition and geometrical, biophysical, mechanical and transport 
properties of the lung alveolar barrier28. It recreates the native viscoelastic microenvironment of 
the cells. Collagen I, the most abundant type of collagen present in connective tissue32, provides 
structural stability for the alveoli, and elastin adds elasticity, which is essential for withstanding 
continuous breathing motions. By tuning the CE ratio and/or adding other ECM molecules, 
scaffolds stiffness can be tailored to specific applications33, which is required to model healthy 
and diseased alveolar environments, such as those present in lung fibrosis34. TEM pictures reveal 
remarkable adhesion of the cells to the CE-membrane and the reproduction of the 
epithelial/endothelial barrier. The membrane enables the diffusion of small and larger molecules 
(FITC-Sodium and RITC-Dextran) and of epithelial cell nutrients necessary to culture cells at the 
air-liquid interface, their physiological microenvironment. The results obtained using cells from 
four patients were similar. Importantly, the absorption and adsorption issue observed with the 
PDMS membranes is almost absent.  
 
The hexagonal gold mesh with a suspended CE-membrane provides cells with small alcoves 
containing an environment similar to that found in an alveolus as measured by a number of 
different parameters. First, the size of each small alcove is the same order of magnitude as the 
diameter of lung alveoli, reported to be around 160–200µm35,36. Second, the borders of the 
alcoves mimic the alveolar walls37,38 that separate alveoli from each other and strengthen the 
stability of the structure. Third, the three-dimensional mechanical stress created within each 
alcove is distributed in a physiological strain gradient. This environment, combined with the CE-
membrane, gives the cells more physiological cell culture conditions and may also enable the 
recreation of biological events that at their onset only involve a limited number of cells. For 
example repetitive microinjuries of the epithelium that are believed to trigger idiopathic lung 
fibrosis are a low-cell number phenomenon that could be mimicked39. Investigations of 
phenotypic changes underlying lung cell pathologies and their effect on downstream signalling 
cascades become possible in tissue-specific primary cell culture microenvironments.  
 
The simple and reproducible production process of the CE-membrane makes it an easy to use 
tool for academic laboratories as well as for larger scale applications, like screening. The unique 
gold mesh also allows the creation of larger cell culture surfaces for specific read-outs requiring 
larger number of cells. The CE-membrane has great versatility as thickness can easily be tuned 
by adapting the volume of the CE solution pipetted onto the gold mesh to suit any number of 
experimental requirements. The thinnest membrane obtained has a thickness comparable to the 
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thinnest porous PDMS membrane reported thus far10. Unlike synthetic polymers, such as PDMS, 
the optically transparent CE-membrane does not require any preliminary coating prior to cell 
seeding. Moreover, the dehydrated extracellular matrix array is robust and can be stored for 
several weeks at room temperature. Ease of use is further improved as the membrane is mainly 
created by surface tension force and does not require clean room conditions. Taken together, 
these characteristics make the CE-membrane a credible alternative to PDMS, with advantages of 
usability, production and stability. 
 
We have developed a lung alveoli array that displays characteristics of the lung parenchyma with 
analogy to native alveolar tissue in a number of physiological parameters. Three key features of 
production and properties were considered in the development of this new generation of organ-
on-a-chip. First, a suspended culturing membrane was created by surface tension force. Second, 
the CE membrane mimics the native ECM of the lung parenchyma. Third, an array of alveoli 
with more physiological geometric proportions was created by the gold mesh. Replacing less 
than optimal PDMS membranes is desirable in in vitro barrier models, and this makes our CE 
membrane a versatile and generic solution that can be expanded to mimic other barrier structures 
found in vivo. The robustness and absorption-free membrane properties make the CE-membrane 
a potentially powerful tool for drug testing, lung diseases modelling and precision medicine 
applications.  
 
 
Materials and Methods 
 
Production of the CE-membrane 
The CE-membrane was produced as follows (Fig. 1). The membrane was based on rat-tail 
collagen type I, high concentration (Corning, New-York, NY, USA), and bovine neck elastin 
powder/lyophilised (Sigma-Aldrich, Buchs, Switzerland). The two molecules were mixed at a 
final concentration of 3.5 mg.mL-1 in a pH 7.4 buffer. A 15 µm-thin gold mesh (Plano GmbH, 
Wetzlar, Germany) with hexagonal pores of 225 μm (inner diameter) and 260 μm (outer 
diameter) was used as a scaffolding to create the biological membrane. The gold mesh was 
successively treated with 5% 3-aminopropyl triethoxysilane (APTES) (Sigma-Aldrich) and 0.1% 
glutaraldehyde (Sigma-Aldrich) to ensure attachment of the membrane. The CE solution was 
pipetted directly on top of the gold mesh. Its thickness was tuned by adapting the volume of the 
CE solution pipetted. After pipetting, the chip was immediately placed at 37°C, 100% humidity 
and 5% CO2 for 2 h 15 min to allow gelation of the membrane. Then, the membrane was placed 
for 48h at room temperature to dry. Membranes were stored at room temperature. Before use, 
membranes were rehydrated with cell culture media for 2h at 37°C.  
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Micro-device fabrication 
To create the air-blood barrier-on-a-chip, a polydimethylsiloxane (PDMS Silgard 184, Dow 
Corning, Midland, MI, USA) plate was attached to a polycarbonate bottom with double tape 
(Arcare 90445-5, Adhesives Research, Glen Mark, PA, USA). The gold mesh with the CE-
membrane was sandwiched between the two chambers (Sup. Fig. 1). This design enabled the 
compartmentalisation of the culture medium in the apical and the basolateral chamber. The top 
layer was produced by PDMS soft lithography. Briefly, a prepolymer was mixed with a curing 
agent at a weight ratio of 10:1 and placed in a vacuum chamber to remove air bubbles. After 
degassing, the PDMS mixture was cast in a mould with two dowel pins located at the border of 
the chip as alignment features. After an incubation at 60°C overnight, the PDMS mixture was 
fully cured, and cut into a rectangular shape of 20 × 15 × 3.2 mm. The bottom layer was made of 
polycarbonate with a central hole of 2mm and two 1.5mm additional holes on both sides of the 
lower part to allow access to the membrane. The top layer can easily be detached from the 
bottom layer to reduce the focal distance required for confocal imaging. Prior to being used, the 
chip was sterilised by autoclaving (CoolCLAVE, Genlantis, San Diego, CA, USA). 
 
Cell culture 
Primary hAEpCs were isolated from patient tissue according to a protocol reported 
previously10,40. Briefly, alveolar epithelial type II (AT II) cells were isolated from tissue 
obtained from healthy areas removed from patients undergoing lung tumor resection 
surgery. All patients gave informed written consent for usage of surgical material for 
research purposes, which was approved by ethical committee from the Ärztekammer des 
Saarlandes. All procedures were carried out in accordance with institutional guidelines 
from Saarland (Germany) and from the Canton of Bern (Switzerland). Cells were cultured 
in Small Airway Growth Medium (SAGM™, Lonza, Basel, Switzerland) with BulletKit 
(CC-3118, Lonza), supplemented with 1% FBS (Sigma) and 1% P/S. RFP-labelled human 
lung microvascular endothelial cells (VeraVec, Angiocrine Biosciences Inc., San Diego, CA, 
USA) were cultured in EGM2 medium (Lonza) supplemented with growth factors according to 
the manufacturer’s instructions (EGM2-MV BulletKit, Lonza). All cell manipulations were 
performed in a sterile flow hood, and cells were maintained at 37°C, 100% humidity and 5% 
CO2. 
  
For monoculture, hAEpCs were seeded with a density of 270,000 cells/cm2 or at 100,000 
cells/cm2 (low concentration condition). The cells were incubated for 24h, allowing the cells to 
adhere to the membrane, and reached confluence after 48h. To create a coculture, the chip was 
flipped, and VeraVec cells were seeded on the basal side of the CE-membrane at 1.0e6 cells/mL. 
After 24h, the chip was flipped again, and the medium was changed to remove all non-attached 
cells. After 48h, epithelial cells were seeded on the apical side at 270,000 cells/cm2. After 24h, 
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50/50 medium (half EGM2-MV supplemented and half SAGM supplemented) was used in both 
monoculture and coculture. Medium was changed daily. 
 
Measurement of the membrane thickness 
The thickness of the membrane was measured with reflective light microscopy. Briefly, the 
membrane was cut at its centre and imaged using the Axioplan microscope (Zeiss, Oberkochen, 
Germany). The thickness was measured using Axiovision software. Confocal imaging (z-stack) 
with LSM710 (Zeiss) was used to confirm the thickness of the membrane. Images were analysed 
with ImageJ software. 
 
Transparency 
The optical transparency of the membrane was evaluated using a light spectrometer (M1000 
Infinite, TECAN, Mannedorf, Switzerland) in the range of 350 to 700nm. Membranes were 
produced by pipetting a solution of the specific material to be tested on the bottom of a 96-well 
plate. The volume of the solution was adapted to obtain a 10µm-thin membrane. 
 
Absorption/adsorption 
The ab- and adsorption of small molecules by the membranes was quantified by immerging them 
in 10µM rhodamine B (Sigma-Aldrich) in PBS for 2h at 37°C. A CE-membrane with ratios 1:1 
and 2:1; a collagen membrane; a polyester membrane with 0.4 and 3µm pore sizes; and 40, 10 
and 3.5 µm porous PDMS membranes were tested. After immersion in rhodamine B, membranes 
were washed twice in PBS for 5 min. The fluorescence of each membrane was measured using a 
standard spectrometer (Infinite M1000, TECAN) with an excitation wavelength of 544 nm and 
an emission of 576 nm. Pictures of the membranes after immersion were taken with a Leica 
DMI400 (Leica Microsystems, Buffalo Grove, IL, USA). The PDMS membranes were 
fabricated by spinning PDMS attached to a silicon wafer at 1650 rpm (resp. 6700 rpm) for 60s to 
obtain a 40µm (resp. 10µm) membrane. The membrane was then cured for 24h at 60°C. The 
3.5µm porous membrane was produced according to a procedure reported previously9.  
 
Permeability assay 
Once the cells were confluent, the lower chamber was filled with cell culture medium. The upper 
chamber was filled with 1μg/mL FITC-Sodium (0.4kDa, Sigma-Aldrich) and 1.5mg/mL RITC-
Dextran (70kDa, Sigma-Aldrich) in 50/50 medium (half EGM2-MV supplemented and half 
SAGM supplemented). The device was incubated for 4h, after which the solution in the upper 
channel was removed and the top chamber was washed three times with PBS. Subsequently, the 
solution from the lower chamber was collected. The samples were tested for fluorescence with a 
multi-well plate reader (M1000 Infinite, TECAN). The FITC-Sodium and RITC-Dextran were 
excited at 460nm and 553nm, respectively. Emission was measured at 515nm and 627nm, 
respectively. The permeability of the air-blood barrier was expressed in terms of relative 
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transport, in that the amplitude of the fluorescent signal of the basal chamber solution was 
normalised to the fluorescence intensity signal of the initial solution of the apical chamber. 
 
Measurement of deflection 
The membrane was cyclically deflected using a homemade electro-pneumatic system generating 
a cyclic negative pressure that can be tuned from 1 to 30 kPa. The deflection measurement was 
performed by the evaluation of the height difference between stretched and unstretched 
membrane. Pressure was applied for 20s, followed by a resting time of 1min. For each 
membrane, a minimum of four hexagons located at the centre of the membrane were measured. 
On each hexagon, two points were measured: one at the centre of the membrane and one on the 
gold mesh hexagon. These values were obtained with an AxioPlan2 Zeiss microscope. Linear 
stress was calculated based on the absolute deflection of the membrane, which was approximated 
as a circular segment (Sup. Fig. 12).  
  
Immunofluorescence 
All immunostaining steps were conducted at room temperature. The chips were washed three 
times with PBS, fixed with 4% paraformaldehyde (Sigma-Aldrich) for 10min and rinsed again 
three times with PBS. The cells were permeabilised with 0.1% Triton X-100 (Sigma-Aldrich) for 
10min and washed three times with PBS. After 45min of blocking in a 2% BSA (Sigma-Aldrich) 
solution, primary antibodies were diluted in the blocking solution. The chip was incubated for 
1.5h. Following incubation, devices were washed three times with PBS, then incubated for 1h 
with the associated secondary antibody. A 1:2000 dilution of Hoechst was added to image cell 
nuclei. Finally, the chip was washed with PBS. The top layer was detached from the bottom to 
image the cells on the membrane. Images were obtained using a confocal microscope (CLSM, 
Zeiss LSM 710). 
 
Scanning electron microscope 
For SEM acquisition, samples were fixed with 2.5% glutaraldehyde (Merck) in 0.1 M cacodylate 
buffer (Merck) at pH 7.4 for 1h at room temperature. After rinsing three times in a 0.1M 
cacodylate buffer, the samples were post-fixed for 10min in a 1% osmium tetroxide solution in 
0.1M sodium cacodylate buffer. After rinsing three times with Acqua Dest (Medical Corner 24, 
Oer-Erkenschwick, Germany), the chips were dehydrated at room temperature in 50%, 70%, 
80% and 95% ethanol for 10min each. Next, they were immersed in 100% ethanol three 
times for 10min. Finally, the samples were immersed in hexamethyldisilane for 10min and then 
dried at room temperature. Samples were mounted onto stubs with adhesive carbon (Portmann 
Instruments, Biel-Benken, Germany) and coated by electron beam evaporation with 
platinum/carbon (thickness of coating: 26nm). Pictures were taken with the DSM982 Gemini 
digital field emission scanning electron microscope (Zeiss) at an acceleration of 5kV and a 
working distance of 3 mm. 
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Transmission electron microscopy 
For TEM acquisition, the chips were fixed with 2.5% glutaraldehyde (Agar Scientific, Essex, 
UK) in 0.15 M HEPES (Sigma-Aldrich) buffer (670mOsm, pH 7.35). The samples were 
placed at 4°C. Samples were post-fixed for 1h in a 1% osmium tetroxide solution in 0.1M 
sodium cacodylate buffer (Merck) and rinsed three times in the same buffer. Next, the chips were 
dehydrated at room temperature with an ethanol concentration series (70%, 80% and 96%) for 
15min each. Then, they were immersed in 100% ethanol (Merck) three times for 10min. The 
chips were embedded in an epoxy solution and incubated at 60°C for 4 days. For samples 
without cells, the chips were directly embedded in the epoxy solution. After removing the PDMS 
surrounding the gold mesh, ultrathin sections (70nm) were cut with an ultramicrotome UC6 
(Leica Microsystems) and mounted on 1mm single-slot copper grids. Pictures were taken with 
a Philips EM 400 transmission electron microscope. 
 
Numerical simulation 
A stationary numerical simulation, using COMSOL Multiphysics 5.3 (COMSOL Multiphysics 
GmbH, Switzerland), was performed to visualize and illustrate the deformation of the CE-
membrane during breathing.  
 
Statistics 
Data are presented as mean ± standard deviation (SD). Two-tailed unpaired Student’s t-test was 
used to assess the significance of differences. Statistical significance was defined as follows: 
*p < 0.05, **p < 0.01, ***p < 0.001. Statistical analysis was performed using GraphPad Prism 6 
software. 
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List of figures: 
 
Figure 1: (a). Schematic of the respiratory tree-like structure ending with alveolar sacs (adapted 
from http://smart.servier.com/). (b). SEM picture of a slice of human lung parenchyma with tiny 
lung alveoli and their ultra-thin air-blood barrier (courtesy of Prof. Dr. Peter Gehr, Institute of 
Anatomy, University of Bern; scale bar: 500µm). (c-d). Schematic of the production of the CE-
membrane used in the 2nd generation lung-on-a chip. A thin gold mesh with an array of 
hexagonal pores of about 260µm is used as a scaffold, on which a drop of collagen-elastin 
solution is pipetted. (e-g). The collagen-elastin gel forms a suspended thin membrane that can be 
stretched at the alveolar level by applying a negative pressure on the basolateral side of the 
membrane. (f-g). Type I (ATI) and type II (ATII) primary human lung alveolar epithelial cells 
are co-cultured with lung endothelial cells on the thin collagen-elastin membrane. (h). Schematic 
of the force balance during the drying of the membrane. FST, FG and o stand for surface tension 
force, gravity and residual stress, respectively.  
 
 
Figure 2: Properties of the thin biological membrane.  (a). Optical clarity of a 10µm-thin CE-
membrane integrated in the gold mesh. Scale bar: 200µm. (b). Picture of an array of several 
hexagons with a CE-membrane. Scale bar: 100µm (c). SEM picture of the CE-membrane 
suspended in one hexagon. (d). Cross-section of the CE-membrane visualized via confocal 
microscopy. Scale bar: 20µm. (e). Characterization of the CE-membrane thickness in function of 
the collagen-elastin solution volume pipetted on top of the gold mesh. (f). Comparison of the 
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spectral absorbance of the CE-membrane and of a polyester membrane (Transwell insert 0,4µm 
pores sizes). (g). Difference of Rhodamine B (10µM) absorption between a 10µm-thin CE-
membrane, a 10µm-thin PDMS membrane and a polyester porous membrane (Transwell insert, 
0.4µm pores sizes). (h). Pictures of CE-membrane (top) and a PDMS membrane (bottom) after 
being exposed to RhoB for two hours. Scale bar: 200µm.  
 
 
Figure 3: Membrane flexibility. (a). Numerical simulation of the deflection of the CE-
membrane array. (b). Picture of a CE-membrane array at rest (left) and exposed to a negative 
pressure of -2kPa (right). Scale bar: 200µm. (c). Linear strain inside the small alveoli in function 
of the applied vacuum and the composition of the CE-membrane. (d) Maximum linear strain 
without (control) and with confluent lung alveolar epithelial cells of two patients at two 
pressures. 
 
Figure 4: Immunostaining of primary human lung alveolar epithelial cells. hAEpC cultured 
on the hexagonal mesh with the CE-membrane after 4 days and at air-liquid interface for 2 days 
with expression of adherent junction markers (E-Cadherin), tight junctions with zonula-
occludens-1 (ZO-1) and merged. Scale bar: 100µm.  
 
 
Figure 5: Primary lung alveolar epithelial cells. (a). Expression of Ki-67 marker on hAEpC at 
day 4. Actin (green), Ki-67 (red) and Hoechst (blue). Scale bar: 10µm. (b). Cellular surface of 
hAEpC at day 2 and 8 in function of the cell seeding concentration. LC: low seeding 
concentration (100’000 cells/cm²) and HC: high seeding concentration (270’000 cell/cm²). (c). 
Expression of surfactant protein-C (SP-C, green), tight junction (Z0-1, red) and nuclei (Hoechst, 
blue) at day 4. Scale bar: 10µm. (d). TEM picture of a hAEpC type-II-like cell at day 4, showing 
its microvilli and empty spaces, where lamellar bodies were located.  Scale bar: 2µm. (e) SEM 
picture of hAEpC at day 14, illustrating tight cell-cell contacts. White arrows: cells border; white 
circle: area zoomed in (f). Scale bar: 10µm. (f) Intersection between three cells at day 14, 
showing their interface and a multitude of microvilli. Blue arrows: cells border. Scale bar: 1µm.  
 
Figure 6: Barrier function. (a). Schematic of the transport of molecules across the CE-
membrane cultured with alveolar epithelial cells. (b) Transport of FITC-Sodium and RITC-
Dextran molecules across the CE-membrane after 4h of incubation with hAEpC. The 
experiments were carried with cells from four patients. (c). TEM picture of tight junction (TJ) 
between two hAEpC. Apical microvillis (MV) typical to type II alveolar epithelial cells can 
clearly be seen. Scale bar: 500nm. 
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Figure 7: Air-blood barrier reproduction. (a).  Confocal pictures (perspective view and cross-
section) of a co-culture of hAEpC (E-Cadherin, green) with human primary endothelial cells 
(Rfp-label, red) on the hexagonal mesh with the CE-membrane. Scale bar: 100µm. (b). TEM 
picture of hAEpC type-I-like cells in co-culture with human lung endothelial cells at day 4. Scale 
bar: 5µm.  
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